Intranasal calcitonin: Began Phase II/III trial

Unigene Inc. (UGNE), Fairfield, N.J. Product: Intranasal calcitonin Business: Musculoskeletal Therapeutic category: Drug delivery, Hormone replacement Target: Osteoclasts Description: Osteoclast inhib...